These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1089744)

  • 21. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression.
    Ishikawa H; Saito K; Kubota E
    J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple CTL subsets generated by H-2.L locus products stimulation: evidence for an antigenic determinant private to H-2.Ld.
    Vazquez A; Senik A; Neauport-Sautes C
    J Immunol; 1980 Jul; 125(1):74-7. PubMed ID: 6155410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sharing of Ia antigens between species. IV. Interspecies cross-reactivity of monoclonal antibodies directed against polymorphic mouse Ia determinants.
    Lunney JK; Osborne BA; Sharrow SO; Devaux C; Pierres M; Sachs DH
    J Immunol; 1983 Jun; 130(6):2786-93. PubMed ID: 6406596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Private specificities of H-2K and H-2D loci as possible selective targets for effector lymphocytes in cell-mediated immunity.
    Brondz BD; Egorov IK; Drizlikh GI
    J Exp Med; 1975 Jan; 141(1):11-26. PubMed ID: 46906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency and cross-reactivity od cytolytic T lymphocyte precursors reacting against male alloantigens.
    Kanagawa O; Louis J; Cerottini JC
    J Immunol; 1982 May; 128(5):2362-6. PubMed ID: 6174631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic control of the immune response. Mapping of the Ir-1 locus.
    McDevitt HO; Deak BD; Shreffler DC; Klein J; Stimpfling JH; Snell GD
    J Exp Med; 1972 Jun; 135(6):1259-78. PubMed ID: 4554451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ia versus K/D antigens in immunological enhancement of tumour allografts. II. Studies with alloimmune sera prepared in recombinant strains.
    Duc HT; Kinsky RG; Voisin GA
    Ann Immunol (Paris); 1979; 130C(3):461-74. PubMed ID: 475347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic T lymphocyte responses in allogeneic radiation bone marrow chimeras. The chimeric host strictly dictates the self-repertoire of Ia-restricted T cells but not H-2K/D-restricted T cells.
    Bradley SM; Kruisbeek AM; Singer A
    J Exp Med; 1982 Dec; 156(6):1650-64. PubMed ID: 6217271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenetic analysis of H-2 mutations. III. Genetic mapping and involvement in immune reactions of the H-2ka mutation.
    Klein J; Forman J; Hauptfeld V; Egorov IK
    J Immunol; 1975 Sep; 115(3):716-8. PubMed ID: 125301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-reactivity between HL-A and H-2 antigens. II. Allogeneic sensitization by xenogeneic soluble lymphocyte antigens (HL-A).
    Götze BD; Lee S; Ferrone S; Pellegrino MA; Reisfeld RA
    Transplant Proc; 1973 Mar; 5(1):467-70. PubMed ID: 4572106
    [No Abstract]   [Full Text] [Related]  

  • 31. Target determinants for F1 hybrid anti-parental H-2d cell-mediated lympholysis: self antigens controlled by the D end.
    Nakamura I; Nakano K; Cudkowicz G
    J Immunol; 1983 May; 130(5):2429-33. PubMed ID: 6187857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sharing of Ia antigens between species. II. Molecular localization of shared Ia determinants implies the existence of more than one I sublocus of the rat MHC.
    Shinohara N; Lunney JK; Sachs DH
    J Immunol; 1978 Aug; 121(2):637-40. PubMed ID: 79611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor.
    Germain RN; Dorf ME; Benacerraf B
    J Exp Med; 1975 Oct; 142(4):1023-8. PubMed ID: 809532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxic T lymphocyte responses against alloantigens exhibit preferential effector cell activity for H-2K or H-2D region products similar to that for H-2 restricted responses.
    Lucas CJ; Levy RB; Shearer GM
    J Immunol; 1981 Apr; 126(4):1255-9. PubMed ID: 6970767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing different reactivity against H-2K and H-2D antigens in normal and ALS-suppressed mice.
    Nĕmec M; Nouza K; Démant P
    Transplant Proc; 1973 Mar; 5(1):275-9. PubMed ID: 4121170
    [No Abstract]   [Full Text] [Related]  

  • 36. A new histogenetic method for minor histocompatability antigen typing.
    Hauptfeld V; Klein J
    J Immunol; 1977 Feb; 118(2):423-6. PubMed ID: 320259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural relation of murine "third locus" (H-2L) major histocompatibility antigens to the products of H-2K and H-2D loci.
    Rose SM; Hansen TH; Cullen SE
    J Immunol; 1980 Nov; 125(5):2044-50. PubMed ID: 7430620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex.
    Ozato K; Hansen TH; Sachs DH
    J Immunol; 1980 Dec; 125(6):2473-7. PubMed ID: 7191868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ir gene control of the cytotoxic T lymphocyte response to Sendai virus: H-2k mice are low responders to Sendai.
    Shapiro ME; Burakoff SJ; Benacerraf B; Finberg RW
    J Immunol; 1981 Dec; 127(6):2571-4. PubMed ID: 6271873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and antigenic characterization of the product of a third polymorphic H-2 locus, H-2L.
    Hansen TH; Sachs DH
    J Immunol; 1978 Oct; 121(4):1469-72. PubMed ID: 81236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.